Covered recipient · General Payments record
SUDHIR AGGARWAL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$48,864.06
- Reported across 632 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,404.57 | 79 |
| Consulting Fee | $150.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $263.50 | 14 |
| Biogen, Inc. | $253.58 | 7 |
| PFIZER INC. | $248.13 | 21 |
| ARGENX US, INC. | $157.01 | 7 |
| Alexion Pharmaceuticals, Inc. | $75.66 | 3 |
| Amneal Pharmaceuticals LLC | $55.44 | 3 |
| Merz Pharmaceuticals, LLC | $53.87 | 3 |
| Axsome Therapeutics, Inc. | $42.47 | 2 |
| Lundbeck LLC | $39.32 | 2 |
| SANOFI-AVENTIS U.S. LLC | $33.80 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $32.37 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $26.44 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.32 | 1 |
| EISAI INC. | $24.35 | 1 |
| Grifols USA, LLC | $23.10 | 1 |
| Acerta Pharma LLC | $21.33 | 1 |
| Neurelis, Inc. | $21.04 | 1 |
| GENZYME CORPORATION | $20.86 | 1 |
| Neurocrine BioSciences, Inc. | $20.68 | 1 |
| AppliedVR Inc | $20.03 | 1 |
| Exact Sciences Corporation | $19.47 | 1 |
| UCB, Inc. | $15.95 | 1 |
| Amgen Inc. | $15.64 | 1 |
| Impel Pharmaceuticals LLC | $15.43 | 1 |
| Genentech USA, Inc. | $15.06 | 1 |
| Janssen Biotech, Inc. | $13.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (80)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.